For over three decades, the goal of this program project grant has been to develop and apply radioactive tracer techniques that provide detailed knowledge of regional biochemistry in living human beings under normal conditions and when affected by diseases, including cancer. Specifically, our present proposal concerns that development, validation and use of radioactive tracers that allow in vivo localization of sigma, opioid, somatostatin and bombesin recognition sites known to be of fundamental importance in oncology. These recognition sites are expressed in a variety of neural and non-neural tumors, and play key roles in the regulation of cell growth and proliferation. Validated biomarkers for in vivo localization of such tumors by positrons emission tomography (PET) and single photon emission computed tomography (SPECT) would aid in cancer diagnosis and management. Our program requires multidisciplinary participation of chemists, biologists, physicists and physicians; and is multidepartmental, involving the Johns Hopkins School of Public Health and the School of Medicine. As a member of a well- coordinated group of scientists, each with special expertise, the investigators will be able to make research advances that are not feasible on an individual basis. The program provides a continuing focus for investigators to obtain new knowledge of in vitro and in vivo biochemistry relevant to cancer through the design, evaluation and application of novel radiotracer techniques. Our translational research will provide useful new tools and 'basic' knowledge that should lead to advances in medical imaging of benefit in the oncology arena.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA032845-38
Application #
6137410
Study Section
Subcommittee G - Education (NCI)
Program Officer
Torres-Anjel, Manuel J
Project Start
1977-12-01
Project End
2001-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
38
Fiscal Year
2000
Total Cost
$683,254
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Madar, Igal; Bencherif, Badredin; Lever, John et al. (2007) Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med 48:207-13
Hardwick, Matthew J; Chen, Ming-Kai; Baidoo, Kwamena et al. (2005) In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: a biomarker of inflammation. Mol Imaging 4:432-8
Lin, Kuo-Shyan; Luu, Andrew; Baidoo, Kwamena E et al. (2005) A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation. Bioconjug Chem 16:43-50
Chen, Ming-Kai; Baidoo, Kwamena; Verina, Tatyana et al. (2004) Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain 127:1379-92
Lin, Kuo-Shyan; Luu, Andrew; Baidoo, Kwamena E et al. (2004) A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier. Bioconjug Chem 15:1416-23
Lever, J R; Ilgin, N; Musachio, J L et al. (1998) Autoradiographic and SPECT imaging of cerebral opioid receptors with an iodine-123 labeled analogue of diprenorphine. Synapse 29:172-82
Sanchez-Roa, P M; Wagner Jr, H N; Villemagne, V L et al. (1998) Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probe. Eur J Pharmacol 358:207-11
Baidoo, K E; Lin, K S; Zhan, Y et al. (1998) Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues. Bioconjug Chem 9:218-25
Baidoo, K E; Scheffel, U; Stathis, M et al. (1998) High-affinity no-carrier-added 99mTc-labeled chemotactic peptides for studies of inflammation in vivo. Bioconjug Chem 9:208-17
Kao, C H; Baidoo, K E; Lever, S Z (1997) Validation and application of a solid phase chemistry method for preparation of high effective specific activity technetium-99m radiopharmaceuticals. Nucl Med Biol 24:499-505

Showing the most recent 10 out of 88 publications